Resources Contact Us Home
Immunological composition of measles virus utilizing recombinant poxvirus

Image Number 18 for United States Patent #5759841.

What is described is a recombinant poxvirus, such as vaccinia virus or canarypox virus, containing foreign DNA from Morbillivirus. In one embodiment, the foreign DNA is expressed in a host by the production of a measles virus glycoprotein. In another embodiment, the foreign DNA is expressed in a host by the production of at least two measles virus glycoproteins. What is also described is a vaccine containing the recombinant poxvirus for inducing an immunological response in a host animal inoculated with the vaccine. By the present invention, cross-protection of dogs against canine distemper is obtained by inoculating the dog with the recombinant poxvirus.

  Recently Added Patents
Systems and methods for managing policies on a computer
Display screen or portion thereof with icon
End to end email monitor
Universal tablet and smartphone holder
Medical imaging probe with rotary encoder
Sampling switch circuit that uses correlated level shifting
Hand sign
  Randomly Featured Patents
Method of manufacturing ink-jet head
Compositions comprising mixtures of silicone fluids and peptizing agents having use as rubber processing aids
Heat sink utilizing the chimney effect
Bioreactor for remediation of pollutants with butane utilizing bacteria
Liquid filling method for a high-temperature and high-pressure vessel and apparatus therefor
Method of reversing carboplatin resistance by inhibition of HGFIN
Continuous wave electron-beam accelerator and continuous wave electron-beam accelerating method thereof
Beam wobbling for increased downlink coverage and capacity
Automobile window shade device and methods of making and using the same
Vibration gyro sensor element with cantilever vibrator extending from substrate and positioned within opening in substrate